$670 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 65 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 31.9% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
TDOC | Sell | TELADOC HEALTH | $25,006,000 | -29.7% | 298,692 | -43.2% | 3.73% | -39.2% |
TNDM | Sell | TANDEM DIABETES CARE | $20,370,000 | -20.2% | 341,714 | -21.0% | 3.04% | -31.0% |
FOLD | Sell | AMICUS THERAPEUTICS | $20,064,000 | -27.3% | 2,059,961 | -40.2% | 2.99% | -37.1% |
AERI | Sell | AERIE PHARMACEUTIC | $18,094,000 | -13.8% | 748,597 | -31.4% | 2.70% | -25.4% |
PTCT | Sell | PTC THERAPEUTICS I | $15,789,000 | +23.8% | 328,738 | -12.9% | 2.36% | +7.0% |
COLL | Sell | COLLEGIUM PHARMACEUT | $15,596,000 | +50.1% | 757,847 | -16.3% | 2.33% | +29.8% |
INSP | Sell | INSPIRE MED SYS INC | $15,213,000 | -5.2% | 205,000 | -22.1% | 2.27% | -18.1% |
IMMU | Sell | IMMUNOMEDICS INC | $14,645,000 | +21.4% | 692,123 | -23.9% | 2.18% | +5.0% |
ASMB | Sell | ASSEMBLY BIOSCIENCES | $14,173,000 | +100.3% | 692,700 | -3.8% | 2.12% | +73.2% |
BMY | Sell | BRISTOL MYERS SQUIBB | $14,088,000 | -1.0% | 219,474 | -21.8% | 2.10% | -14.4% |
APLS | Sell | APELLIS PHARMACEUTIC | $13,944,000 | -41.9% | 455,393 | -54.3% | 2.08% | -49.8% |
GBT | Sell | GLOBAL BLOOD THERA | $13,878,000 | +18.7% | 174,594 | -27.6% | 2.07% | +2.6% |
CI | Sell | CIGNA CORP | $10,655,000 | +12.5% | 52,107 | -16.5% | 1.59% | -2.7% |
MRK | Sell | MERCK & CO INC | $10,314,000 | +4.2% | 113,400 | -3.6% | 1.54% | -9.9% |
ALNY | Sell | ALNYLAM PHARMACUETCL | $10,089,000 | -31.9% | 87,600 | -52.5% | 1.50% | -41.2% |
IRTC | Sell | IRHYTHM TECHNOLOGIES | $9,362,000 | -32.7% | 137,500 | -26.8% | 1.40% | -41.8% |
ZBH | Sell | ZIMMER BIOMET HLDS | $7,372,000 | -19.4% | 49,249 | -26.1% | 1.10% | -30.2% |
SRPT | Sell | SAREPTA THERAPEUTICS | $7,324,000 | +15.2% | 56,760 | -32.7% | 1.09% | -0.4% |
ABT | Sell | ABBOTT LABS | $6,705,000 | -8.1% | 77,198 | -11.5% | 1.00% | -20.6% |
MDT | Sell | MEDTRONIC PLC | $6,257,000 | -20.7% | 55,151 | -24.1% | 0.93% | -31.4% |
CHNG | Sell | CHANGE HEALTHCARE IN | $5,943,000 | +21.3% | 362,603 | -10.6% | 0.89% | +4.8% |
TMO | Sell | THERMO FISHER SCI | $3,817,000 | -28.0% | 11,750 | -35.4% | 0.57% | -37.7% |
GILD | Sell | GILEAD SCIENCES INC | $3,337,000 | -78.7% | 51,350 | -79.2% | 0.50% | -81.6% |
ALXN | Sell | ALEXION PHARM INC | $2,747,000 | -23.6% | 25,399 | -30.8% | 0.41% | -33.9% |
EVLO | Sell | EVELO BIOSCIENCES | $2,568,000 | -42.5% | 632,582 | -13.7% | 0.38% | -50.3% |
MGTX | Sell | MEIRAGTX HLDINGS PLC | $1,868,000 | -43.0% | 93,306 | -54.6% | 0.28% | -50.6% |
AGIO | Sell | AGIOS PHARMACEUTIC | $1,628,000 | +10.7% | 34,100 | -24.9% | 0.24% | -4.3% |
PHAS | Sell | PHASEBIO PHARMACEU | $1,088,000 | +33.2% | 178,000 | -9.2% | 0.16% | +14.9% |
FIXX | Sell | HOMOLOGY MEDICINES | $904,000 | -32.8% | 43,681 | -41.3% | 0.14% | -41.8% |
RDY | Sell | DR REDDYS LABS LTDadr | $631,000 | -57.7% | 15,554 | -60.5% | 0.09% | -63.6% |
SAGE | Sell | SAGE THERAPEUTICS | $552,000 | -62.5% | 7,650 | -27.1% | 0.08% | -67.7% |
UMRX | Sell | UNUM THERAPEUTICS | $106,000 | -95.2% | 146,745 | -90.3% | 0.02% | -95.8% |
AGN | Exit | ALLERGAN PLC | $0 | – | -4,800 | -100.0% | -0.14% | – |
SBPH | Exit | SPRING BK PHARMACE | $0 | – | -276,656 | -100.0% | -0.16% | – |
URGN | Exit | UROGEN PHARMA LTD | $0 | – | -65,063 | -100.0% | -0.27% | – |
SVRA | Exit | SAVARA INC | $0 | – | -710,310 | -100.0% | -0.32% | – |
ALBO | Exit | ALBIREO PHARMA INC | $0 | – | -147,211 | -100.0% | -0.51% | – |
VRAY | Exit | VIEWRAY INC | $0 | – | -1,240,865 | -100.0% | -0.62% | – |
FTSV | Exit | FORTY SEVEN INC | $0 | – | -814,414 | -100.0% | -0.90% | – |
OBSV | Exit | OBSEVA SA | $0 | – | -643,151 | -100.0% | -0.92% | – |
PFE | Exit | PFIZER INC | $0 | – | -183,528 | -100.0% | -1.14% | – |
XLRN | Exit | ACCELERON PHARMA | $0 | – | -227,596 | -100.0% | -1.55% | – |
LJPC | Exit | LA JOLLA PHARMACLS | $0 | – | -1,158,271 | -100.0% | -1.76% | – |
RARX | Exit | RA PHARMACEUTICALS | $0 | – | -451,247 | -100.0% | -1.84% | – |
NVS | Exit | NOVARTIS AGsponsored adr | $0 | – | -147,846 | -100.0% | -2.22% | – |
SWAV | Exit | SHOCKWAVE MEDICAL | $0 | – | -573,434 | -100.0% | -2.96% | – |
WMGI | Exit | WRIGHT MED GROUP N V | $0 | – | -1,063,872 | -100.0% | -3.79% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
PFIZER INC | 35 | Q3 2023 | 6.3% |
MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
SEQUENOM INC | February 12, 2014 | ? | ? |
INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-14 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
SC 13G/A | 2023-02-13 |
SC 13G | 2023-02-13 |
13F-HR | 2023-02-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.